Diffuse Large B Cell Non-Hodgkin Lymphoma
2 clinical trials · Condition
◉ Watch Diffuse Large B Cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL (NCT02141451) | Masonic Cancer Center, University of Minnesota | 2014-05-01 |
Track Diffuse Large B Cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.